hrp0086p1-p740 | Pituitary and Neuroendocrinology P1 | ESPE2016
, Lam Francis
, Besser Rachel
, Goedhart Claire
, Brain Caroline
Background: Adolescents presenting with persistent gender dysphoria (GD) may undergo pubertal suspension via the use of GnRH analogues such as triptorelin (Gonapeptyl Depot) to allow further consideration of the dysphoria. Locally, a standard monthly dose of this drug is administered for an initial target duration of 12 months prior to re-assessment.Objective and hypotheses: The need to obtain full gonadotrophin and sex hormone suppression to ensure accu...